Zevra Therapeutics Inc. Common Stock (ZVRA)

Stock · NASDAQ · Health Care

$11.56as of 8/28/2026

Price chart

Insider transactionsShow all transaction typesRevenue Growth

No technical signal is currently active for this symbol.

Support level

$8.76

Industry

Biotechnology: Pharmaceutical Preparations

Chosen by industry and closest market cap.

ZVRA
Zevra Therapeutics Inc. Common Stock
$11.56
▼ 2.41%
Market cap $594.40MP/E —
CRMD
CorMedix Inc. Common Stock
$8.31
▼ 0.06%
Market cap $592.31MP/E 3.53
$6.13$14.96
MPLT
MapLight Therapeutics Inc. Common Stock
$12.64
▲ 0.80%
Market cap $569.09MP/E —
$9.1$40.43
CBIO
Crescent Biopharma Inc. Common Stock
$17.74
▼ 0.14%
Market cap $552.33MP/E —
$8.72$27.41
BBOT
BridgeBio Oncology Therapeutics Inc. Common Stock
$8.74
▼ 4.79%
Market cap $660.88MP/E —
$7$14.87
ARVN
Arvinas Inc. Common Stock
$9.16
▼ 0.87%
Market cap $520.04MP/E 62.96
$6.97$14.51
CLYM
Climb Bio Inc. Common Stock
$14.56
▼ 3.32%
Market cap $676.28MP/E —
$1.54$18.33

Symbol	Market cap	P/E ratio	Price	1D	52-week range
ZVRA Zevra Therapeutics Inc. Common Stock	$594.40M	—	$11.56	▼ 2.41%
CRMD CorMedix Inc. Common Stock	$592.31M	3.53	$8.31	▼ 0.06%	$6.13$14.96
MPLT MapLight Therapeutics Inc. Common Stock	$569.09M	—	$12.64	▲ 0.80%	$9.1$40.43
CBIO Crescent Biopharma Inc. Common Stock	$552.33M	—	$17.74	▼ 0.14%	$8.72$27.41
BBOT BridgeBio Oncology Therapeutics Inc. Common Stock	$660.88M	—	$8.74	▼ 4.79%	$7$14.87
ARVN Arvinas Inc. Common Stock	$520.04M	62.96	$9.16	▼ 0.87%	$6.97$14.51
CLYM Climb Bio Inc. Common Stock	$676.28M	—	$14.56	▼ 3.32%	$1.54$18.33

P/E shows — for peers not currently carrying a live signal of their own.

March 31, 2026

Top holders this quarter

See the full, filterable feed with live charts on the MarketWall dashboard.